Detection sensitivity of lymph nodes of various sizes using USPIO nanoparticles in magnetic resonance imaging

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 3, 2010, Pages 496-499

  Oghabian, Mohammad Ali ^a   Gharehaghaji, Nahideh ^b   Amirmohseni, Saeedeh ^a   Khoei, Samideh ^a   Guiti, Masoomeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Axillary lymph node; Detection sensitivity; Iron oxide nanoparticles; Magnetic resonance imaging; USPIO

Indexed keywords

BODY FLUIDS; MACROPHAGES; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; PATHOLOGY; SUPERPARAMAGNETISM;

AXILLARY LYMPH NODES; CONTRAST AGENT; DETECTION SENSITIVITY; DIPOLAR RELAXATION; EARLY DETECTION; GRADIENT ECHO; INTRAVENOUS INJECTIONS; IRON OXIDE NANOPARTICLE; LYMPH NODE; MRI CONTRAST AGENTS; PULSE SEQUENCE; SIGNAL CHANGES; SUSCEPTIBILITY ARTIFACTS; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

IRON OXIDES;

NANOMAG D SPIO; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; DEXTRAN; FERUMOXTRAN-10; MAGNETITE; MAGNETITE NANOPARTICLE; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; ARTIFACT; AXILLARY LYMPH NODE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE CALCULATION; DRUG ACCUMULATION; IMAGE QUALITY; LOW DRUG DOSE; LYMPHOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; ANIMAL; DIAGNOSTIC USE; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; LYMPHATIC METASTASIS; NANOMEDICINE; ORGAN SIZE; PATHOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; ARTIFACTS; DEXTRANS; FERROSOFERRIC OXIDE; INJECTIONS, INTRAVENOUS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NANOMEDICINE; NANOPARTICLES; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 77952695181     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.11.005     Document Type: Article

References (9)

1. Vassallo P., Matei C., Heston W.D.W., et al. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumour bearing lymph nodes. Radiology 193 (1994) 501-506
2. Gharehaghaji N., Oghabian M.A., Sarkar S., Amirmohseni S., and Ghanaati H. Optimization of pulse sequences in magnetic resonance lymphography of axillary lymph nodes using magnetic nanoparticles. J Nanosci Nanotechnol 9 (2009) 4448-4452
3. Kim J.K., Kucharczyk W., and Henkelman R.M. Cavernous hemangiomas: dipolar susceptibility artifacts at MR imaging. Radiology 187 (1993) 735-741
4. Gharehaghaji N., Oghabian M.A., Sarkar S., Darki F., and Beitollahi A. How size evaluation of lymph node is protocol dependent in MRI when using ultrasmall superparamagnetic iron oxide nanoparticles. J Magn Magn Mater 321 (2009) 1563-1565
5. Hudgins P.A., Anzai Y., Morris M.R., and Lucas M.A. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study. AJNR Am J Neuroradiol 23 (2002) 649-656
6. Bengele H.H., Palmacci S., Rogers J., Jung C.W., Crenshaw J., and Josephson L. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. Magn Reson Imaging 12 (1994) 433-442
7. Herrera-Ornales L., Justiniano J., Castillo N., et al. Metastases in small lymph nodes from colon cancer. Arch Surg 122 (1987) 1253-1256
8. Firouznia K., Amirmohseni S., Guiti M., Amanpour S., Baitollahi A., Arab Kharadmand A., et al. MR relaxivity measurement of iron oxide nano-particles for MR lymphography applications. Pak J Biol Sci 11 (2008) 607-612
9. Weissleder R., Heautot J.F., Schaffer B.K., Nossiff N., Papisov M.I., Bogdanov A., et al. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology 191 (1994) 225-230